Beximco Pharmaceuticals Limited (AIM: BXP)

Beximco Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 19, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	252	355	473	607	675	267
Market Cap Growth	-58.23%	-24.94%	-22.18%	-10.02%	152.96%	-15.36%
Enterprise Value	299	420	574	741	745	369
Last Close Price	0.36	0.37	0.31	0.60	0.72	0.27
PE Ratio	6.78	9.04	14.14	13.46	15.43	7.98
PS Ratio	0.72	1.19	1.66	1.99	2.68	1.10
PB Ratio	0.61	1.02	1.37	1.55	2.12	0.86
P/TBV Ratio	0.74	1.24	1.70	1.96	2.25	0.91
P/FCF Ratio	5.86	8.27	17.75	28.75	22.58	8.51
P/OCF Ratio	4.43	6.30	10.72	13.23	13.13	5.06
EV/Sales Ratio	1.00	1.40	2.02	2.43	2.96	1.52
EV/EBITDA Ratio	4.37	6.25	8.84	10.20	11.70	5.98
EV/EBIT Ratio	5.28	7.52	11.48	12.78	13.75	7.22
EV/FCF Ratio	8.63	9.78	21.57	35.06	24.92	11.76
Debt / Equity Ratio	0.09	0.12	0.22	0.28	0.20	0.32
Debt / EBITDA Ratio	0.48	0.60	1.18	1.50	1.02	1.62
Debt / FCF Ratio	0.89	0.95	2.89	5.16	2.18	3.18
Asset Turnover	0.64	0.64	0.58	0.59	0.58	0.52
Inventory Turnover	1.82	1.87	1.77	1.91	2.03	1.91
Quick Ratio	0.62	0.52	0.37	0.35	0.39	0.35
Current Ratio	2.43	2.18	1.57	1.45	1.47	1.15
Return on Equity (ROE)	11.66%	11.79%	9.81%	12.19%	14.73%	11.31%
Return on Assets (ROA)	7.61%	7.48%	6.38%	6.95%	7.75%	6.76%
Return on Capital (ROIC)	9.18%	8.92%	7.49%	8.06%	8.98%	7.75%
Earnings Yield	18.29%	11.06%	7.07%	7.43%	6.48%	12.52%
FCF Yield	17.08%	12.09%	5.63%	3.48%	4.43%	11.75%
Dividend Yield	0.06%	7.37%	8.06%	5.12%	4.16%	4.87%
Payout Ratio	26.64%	27.20%	33.98%	31.68%	11.28%	17.13%
Buyback Yield / Dilution	-	-	-	-	0.00%
Total Shareholder Return	0.06%	7.37%	8.06%	5.12%	4.16%	4.87%

Source: S&P Capital IQ. Standard template. Financial Sources.